Sex differences in heart failure

Evann Eisenberg, Katherine E. Di Palo, Ileana L. Pina

Research output: Contribution to journalReview article

9 Citations (Scopus)

Abstract

Heart failure (HF) numbers continue to grow in the United States and approximately 50% of patients living with HF are women. For the provider, it is critical to understand the role that gender plays in recognition, diagnosis, and management. The purpose of this literature review is to highlight the prevalence of heart failure in women and discuss gender variations in epidemiology, symptoms, pharmacology, and treatment as well as examine the representation of women in clinical trials.

Original languageEnglish (US)
Pages (from-to)211-216
Number of pages6
JournalClinical Cardiology
Volume41
Issue number2
DOIs
StatePublished - Feb 1 2018

Fingerprint

Sex Characteristics
Heart Failure
Epidemiology
Clinical Trials
Pharmacology
Therapeutics

Keywords

  • Gender Differences
  • Heart Failure
  • Women

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Sex differences in heart failure. / Eisenberg, Evann; Di Palo, Katherine E.; Pina, Ileana L.

In: Clinical Cardiology, Vol. 41, No. 2, 01.02.2018, p. 211-216.

Research output: Contribution to journalReview article

Eisenberg, E, Di Palo, KE & Pina, IL 2018, 'Sex differences in heart failure', Clinical Cardiology, vol. 41, no. 2, pp. 211-216. https://doi.org/10.1002/clc.22917
Eisenberg, Evann ; Di Palo, Katherine E. ; Pina, Ileana L. / Sex differences in heart failure. In: Clinical Cardiology. 2018 ; Vol. 41, No. 2. pp. 211-216.
@article{deb61fa8a8fc488a80f671c1bfcf0476,
title = "Sex differences in heart failure",
abstract = "Heart failure (HF) numbers continue to grow in the United States and approximately 50{\%} of patients living with HF are women. For the provider, it is critical to understand the role that gender plays in recognition, diagnosis, and management. The purpose of this literature review is to highlight the prevalence of heart failure in women and discuss gender variations in epidemiology, symptoms, pharmacology, and treatment as well as examine the representation of women in clinical trials.",
keywords = "Gender Differences, Heart Failure, Women",
author = "Evann Eisenberg and {Di Palo}, {Katherine E.} and Pina, {Ileana L.}",
year = "2018",
month = "2",
day = "1",
doi = "10.1002/clc.22917",
language = "English (US)",
volume = "41",
pages = "211--216",
journal = "Clinical Cardiology",
issn = "0160-9289",
publisher = "John Wiley and Sons Inc.",
number = "2",

}

TY - JOUR

T1 - Sex differences in heart failure

AU - Eisenberg, Evann

AU - Di Palo, Katherine E.

AU - Pina, Ileana L.

PY - 2018/2/1

Y1 - 2018/2/1

N2 - Heart failure (HF) numbers continue to grow in the United States and approximately 50% of patients living with HF are women. For the provider, it is critical to understand the role that gender plays in recognition, diagnosis, and management. The purpose of this literature review is to highlight the prevalence of heart failure in women and discuss gender variations in epidemiology, symptoms, pharmacology, and treatment as well as examine the representation of women in clinical trials.

AB - Heart failure (HF) numbers continue to grow in the United States and approximately 50% of patients living with HF are women. For the provider, it is critical to understand the role that gender plays in recognition, diagnosis, and management. The purpose of this literature review is to highlight the prevalence of heart failure in women and discuss gender variations in epidemiology, symptoms, pharmacology, and treatment as well as examine the representation of women in clinical trials.

KW - Gender Differences

KW - Heart Failure

KW - Women

UR - http://www.scopus.com/inward/record.url?scp=85042529264&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042529264&partnerID=8YFLogxK

U2 - 10.1002/clc.22917

DO - 10.1002/clc.22917

M3 - Review article

VL - 41

SP - 211

EP - 216

JO - Clinical Cardiology

JF - Clinical Cardiology

SN - 0160-9289

IS - 2

ER -